NO864971L - Fremgangsmaate for fremstilling av monoklonale antistoffer som er kryssbeskyttende overfor p. aeruginosaserotyper. - Google Patents

Fremgangsmaate for fremstilling av monoklonale antistoffer som er kryssbeskyttende overfor p. aeruginosaserotyper.

Info

Publication number
NO864971L
NO864971L NO86864971A NO864971A NO864971L NO 864971 L NO864971 L NO 864971L NO 86864971 A NO86864971 A NO 86864971A NO 864971 A NO864971 A NO 864971A NO 864971 L NO864971 L NO 864971L
Authority
NO
Norway
Prior art keywords
aeruginosasery
procedure
preparation
types
monoclonal antibodies
Prior art date
Application number
NO86864971A
Other languages
English (en)
Other versions
NO178718C (no
NO178718B (no
NO864971D0 (no
Inventor
Anthony W Siadak
Mae J Rosok
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of NO864971D0 publication Critical patent/NO864971D0/no
Publication of NO864971L publication Critical patent/NO864971L/no
Publication of NO178718B publication Critical patent/NO178718B/no
Publication of NO178718C publication Critical patent/NO178718C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO864971A 1985-12-10 1986-12-10 Preparat for anvendelse in vitro, udödelig, transformert cellelinje og humant, monoklonalt antistoff, samt sett eller utstyr for anvendelse ved påvisning in vitro av tilstedeværelse av Pseudomonas aeruginosa NO178718C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80739485A 1985-12-10 1985-12-10
US93117986A 1986-11-24 1986-11-24

Publications (4)

Publication Number Publication Date
NO864971D0 NO864971D0 (no) 1986-12-10
NO864971L true NO864971L (no) 1987-06-11
NO178718B NO178718B (no) 1996-02-12
NO178718C NO178718C (no) 1996-05-22

Family

ID=27123006

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864971A NO178718C (no) 1985-12-10 1986-12-10 Preparat for anvendelse in vitro, udödelig, transformert cellelinje og humant, monoklonalt antistoff, samt sett eller utstyr for anvendelse ved påvisning in vitro av tilstedeværelse av Pseudomonas aeruginosa

Country Status (21)

Country Link
US (4) US5378812A (no)
JP (1) JPH07116237B2 (no)
KR (1) KR910008361B1 (no)
CN (1) CN86108380A (no)
AT (1) AT400441B (no)
BE (1) BE905890A (no)
CH (1) CH677362A5 (no)
DE (1) DE3642095C2 (no)
DK (1) DK594586A (no)
FI (1) FI86377C (no)
FR (1) FR2593826B1 (no)
GB (1) GB2185266B (no)
HU (1) HUT41836A (no)
IE (1) IE59741B1 (no)
IT (1) IT1199735B (no)
LU (1) LU86711A1 (no)
NL (1) NL8603132A (no)
NO (1) NO178718C (no)
NZ (1) NZ218499A (no)
PT (1) PT83894B (no)
SE (1) SE468831B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies
US5521085A (en) * 1986-12-15 1996-05-28 Mitsui Toatsu Chemicals, Inc. Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
KR910004868B1 (ko) * 1986-12-15 1991-07-15 미츠이 도아츠 가가쿠 가부시기가이샤 인체 단일 클론항체 및 그것을 활성성분으로 함유하는 감염증의 예방 및 치료용 약학적 제제
WO1990011350A1 (fr) * 1989-03-20 1990-10-04 Mitsui Toatsu Chemicals, Inc. Anticorps monoclonal humain reagissant avec le pseudomonas aeruginosa, cellule produisant cet anticorps, procede de production et preparation pharmaceutique
JPH01197500A (ja) * 1988-01-29 1989-08-09 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
EP0382031A3 (en) * 1989-02-10 1991-06-26 Miles Inc. Monoclonal antibodies in immune serum globulin
US4994269A (en) * 1989-03-17 1991-02-19 Miles Inc. Topical use of antibodies for prevention or treatment of pseudomonas infections
JPH02283294A (ja) * 1989-04-24 1990-11-20 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
JPH0329196A (ja) * 1989-05-09 1991-02-07 Advanced Micro Devicds Inc センス増幅器
US5858728A (en) * 1991-03-13 1999-01-12 Common Services Agency Monoclonal antibody against LPS core
US20030096315A1 (en) 2000-05-03 2003-05-22 Sanders Mitchell C. Device for detecting bacterial contamination and method of use
US9017963B2 (en) * 2002-01-31 2015-04-28 Woundchek Laboratories (Us), Inc. Method for detecting microorganisms
EP1506217A4 (en) * 2002-05-29 2006-04-12 Jackson H M Found Military Med METHOD FOR IDENTIFYING GENOMIC AND PROTEOMIC BIOMARKERS FOR CYSTIC FIBROSIS, BIOMARKER COMPRISING ARRANGEMENTS AND METHOD FOR APPLYING THE ARRANGEMENTS
WO2004047778A1 (en) * 2002-11-26 2004-06-10 Uc Tech Materials and methods for preventing and treating microbe-mediated epithelial disorders
PL215172B1 (pl) * 2003-01-31 2013-10-31 Ethicon Inc Sposób wykrywania Escherichia coli, biosensor do wykrywania Escherichia coli i zestaw do wykrywania Escherichia coli
EP1692510B1 (en) 2003-11-03 2008-01-02 Ethicon, Inc. Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
EP1690875A1 (en) * 2005-02-14 2006-08-16 Kenta Biotech AG Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype
EP2012669B1 (en) * 2006-05-01 2013-03-13 Bioness Neuromodulation Ltd Improved functional electrical stimulation systems
JP2012516897A (ja) * 2009-02-04 2012-07-26 カロバイオス ファーマシューティカルズ インコーポレイティッド シュードモナス・エルギノーサ（ＰｓｅｕｄｏｍｏｎａｓＡｅｒｕｇｉｎｏｓａ）感染の治療のための抗生物質と抗体療法との組み合わせ
CN102858799A (zh) * 2010-02-18 2013-01-02 明治制果药业株式会社 抗铜绿假单胞菌的i血清型脂多糖的抗体
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
JPS58216125A (ja) * 1982-06-09 1983-12-15 Asahi Chem Ind Co Ltd ヒト抗体の産生方法
JPS5929622A (ja) * 1982-08-10 1984-02-16 Meiji Seika Kaisha Ltd モノクロ−ナル抗体、その製造法およびその用途
AU585200B2 (en) * 1983-05-06 1989-06-15 Velos Group Monoclonal antibodies reactive with endotoxin core
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US4683196A (en) * 1983-12-12 1987-07-28 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
EP0168422A1 (en) * 1983-12-12 1986-01-22 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
JP2565303B2 (ja) * 1984-05-25 1996-12-18 三井東圧化学株式会社 緑膿菌感染症の予防治療剤
JPS60248625A (ja) * 1984-05-25 1985-12-09 Mitsui Toatsu Chem Inc 抗緑膿菌モノクロ−ナル抗体、その製法ならびに用途
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
AU597877B2 (en) * 1984-12-26 1990-06-14 Teijin Limited Anti-pseudomonas aeruginosa human monoclonal antibody
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
JPS6229175A (ja) * 1985-07-29 1987-02-07 Nippon Telegr & Teleph Corp <Ntt> 電界効果型トランジスタの製造方法
DE3689713T2 (de) * 1985-08-01 1994-07-07 Miles Inc Schützende Antikörper gegen serotypische Determinanten von flagellären Antigenen.
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies

Also Published As

Publication number Publication date
ATA328286A (de) 1995-05-15
IT8622630A0 (it) 1986-12-10
JPH07116237B2 (ja) 1995-12-13
IE59741B1 (en) 1994-03-23
GB8629540D0 (en) 1987-01-21
FR2593826B1 (fr) 1990-11-16
DE3642095C2 (de) 1998-10-01
SE468831B (sv) 1993-03-29
KR910008361B1 (ko) 1991-10-12
CH677362A5 (no) 1991-05-15
FI865027A (fi) 1987-06-11
PT83894A (en) 1987-01-01
BE905890A (fr) 1987-06-10
US5628996A (en) 1997-05-13
IE863230L (en) 1987-06-10
US5378812A (en) 1995-01-03
US5627067A (en) 1997-05-06
SE8605295L (sv) 1987-06-11
AT400441B (de) 1995-12-27
JPS62187417A (ja) 1987-08-15
FI86377B (fi) 1992-05-15
DK594586D0 (da) 1986-12-10
GB2185266B (en) 1990-09-05
HUT41836A (en) 1987-05-28
FI865027A0 (fi) 1986-12-10
SE8605295D0 (sv) 1986-12-10
NO178718C (no) 1996-05-22
NO178718B (no) 1996-02-12
NO864971D0 (no) 1986-12-10
DK594586A (da) 1987-06-11
DE3642095A1 (de) 1987-07-02
KR870005648A (ko) 1987-07-06
PT83894B (pt) 1989-07-31
CN86108380A (zh) 1987-10-28
GB2185266A (en) 1987-07-15
NL8603132A (nl) 1987-07-01
LU86711A1 (fr) 1988-07-14
US5662905A (en) 1997-09-02
FR2593826A1 (fr) 1987-08-07
FI86377C (fi) 1992-08-25
NZ218499A (en) 1990-04-26
IT1199735B (it) 1988-12-30

Similar Documents

Publication Publication Date Title
NO864971L (no) Fremgangsmaate for fremstilling av monoklonale antistoffer som er kryssbeskyttende overfor p. aeruginosaserotyper.
NO163668C (no) Fremgangsmaate for fremstilling av immunogent kompleks.
NO874764L (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
NO159667C (no) Fremgangsmaate for fremstilling av kikhostetoksid.
RO86213A (ro) Procedeu pentru prepararea izobutenei
NO158136C (no) Fremgangsmaate til fremstilling av tiadiazolderivater.
NO855067L (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
NO812519L (no) Fremgangsmaate for fremstilling av kolesterase.
NO853066L (no) Fremgansmaate til fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO851920L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO163061C (no) Fremgangsmaate til fremstilling av ferromangan.
NO863389L (no) Fremgangsmaate til fremstilling av substituerte toluidiner.
NO162018C (no) Fremgangsmaate for fremstilling av 4-metyl-5-alkyltiometylimidazoler.
NO157143C (no) Fremgangsmaate for fremstilling av karbapen-2-em-derivater.
NO165637C (no) Fremgangsmaate for fremstilling av etoksylert lignitt.
NO810114L (no) Fremgangsmaate for fremstilling av kijanimicin.
ES522653A0 (es) Procedimiento de preparacion de derivados de piperacina.
NO161353C (no) Fremgangsmaate for fremstilling av pastiller.
NO863769D0 (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
NO852418L (no) Fremgangsmaate for fremstilling av aminderivater.
NO864087L (no) Fremgangsmaate for fremstilling av aroylthiazoloner.
NO166709C (no) Fremgangsmaate for fremstilling av akrylamider.
NO851319L (no) Fremgangsmaate for fremstilling av eburnanderivater.
NO162559C (no) Fremgangsmaate til fremstilling av kondenserte as-triazinderivater.
NO821874L (no) Fremgangsmaate for fremstilling av fenoletere.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2001